United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Medac resubmits treosulfan NDA to FDA, says Medexus Pharmaceuticals Medexus Pharmaceuticals said that its strategic partner medac has resubmitted the new drug application (NDA) for treosulfan with… bySrinathJuly 30, 2022
